Amma Asare, MD, PhD, is a fellow in gynecologic oncology at The University of Texas MD Anderson Cancer Center. She is a developmental oncologist currently focusing on clonal evolution and resistance in ovarian cancer. She received her MD PhD from the Tri Institutional MD PhD program including a PhD in developmental biology from Rockefeller University … Read more
Led by a team of UNC researchers, this study explored the relationship between survival and how quickly patients are diagnosed with ovarian cancer.
Linda Van Le, MD, a UNC Health gynecologic oncologist, shares the warning signs of ovarian cancer. The lack of screening and vague symptoms mean ovarian cancer is typically not found until it’s in an advanced stage.
Researchers have learned more about an enzyme found to be overly expressed in patients with hereditary breast cancer, ovarian cancer and prostate cancer.
Researchers led by Hector L. Franco, PhD, have determined for the first time, cell-by-cell, the genetic and epigenetic state of ovarian and endometrial tumors.
She ROCKS supports the work of UNC Lineberger’s Victoria Bae-Jump, MD, and her work focusing on advancing the prevention, early detection and treatment of ovarian cancer.